Individualised selection of left-sided breast cancer patients for proton therapy based on cost-effectiveness.

ABSTRACT:

Introduction

The significantly greater cost of proton therapy compared with X-ray therapy is frequently justified by the expected reduction in normal tissue toxicity. This is often true for indications such as paediatric and skull base cancers. However, the benefit is less clear for other more common indications such as breast cancer, and it is possible that the degree of benefit may vary widely between these patients. The aim of this work was to demonstrate a method of individualised selection of left-sided breast cancer patients for proton therapy based on cost-effectiveness of treatment.

Methods

16 left-sided breast cancer patients had a treatment plan generated for the delivery of intensity-modulated proton therapy (IMPT) and of intensity-modulated photon therapy (IMRT)

SUBMITTER: Austin AM 

PROVIDER: S-EPMC7890920 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature